NCT05438589View on ClinicalTrials.gov

Novel Rapid POC Diagnostics for COVID-19

CompletedOBSERVATIONAL

Enrollment

1,283

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions

COVID-19 Respiratory Infection

Trial Locations (2)

Unknown

National Center for Disease Control, Tbilisi

Ezintsha, Johannesburg

All Listed Sponsors

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER